Lung Cancer

Roche Launches Test for differential Diagnosis of Mesothelioma

The automated immunohistochemistry test helps pathologists identify malignant mesothelioma while preserving biopsy tissue for additional testing.

Lung Cancer

Low-cost Blood Test on a Chip Diagnoses Lung Cancer Without DNA Sequencing

Tel Aviv University researchers have developed a low-cost blood test that detects lung cancer by analyzing optical DNA fingerprints, achieving 93.1% sensitivity and 90.3% specificity.

Lung Cancer

Blood Test Boosts Lung Cancer Screening Participation

New clinical utility data showed that offering a blood-based lung cancer test increased screening participation compared with low-dose CT screening alone.

Liquid Biopsy Technology Detects Over 95% of Early-Stage Cancers in Blinded Validation Study

Mar 26, 2026 | Colorectal, Lung Cancer

A novel enrichment method produces virtually pure circulating tumor DNA from blood samples, showing strong sensitivity and specificity across colorectal and lung cancer patients.

Nucleosome Liquid Biopsy Shows Promise for Lung Cancer Risk Stratification

Mar 26, 2026 | Lung Cancer

Preoperative blood testing using H3K27Me3-nucleosome levels may help clinicians identify which non-small cell lung cancer patients need closer follow-up or additional treatment.

Largest Lung Nodule Biomarker Validation Study Backs Earlier Cancer Detection

Mar 25, 2026 | Lung Cancer

A pooled analysis of more than 1,100 patients across four cohort studies supports the clinical utility of the Nodify CDT test in identifying high-risk lung nodules.

Personalis Receives Medicare Coverage for NeXT Personal in Lung Cancer Surveillance

Feb 18, 2026 | Lung Cancer

The NeXT Personal molecular residual disease test can now be used for surveillance of patients with Stage I to III non-small cell lung cancer.

Blood Test Identifies Lung Cancer Patients Who Will Respond to Immunotherapy

Jan 27, 2026 | Lung Cancer

Researchers at Mass General Brigham have developed a blood test that predicts tarlatamab response in small cell lung cancer, showing 85% sensitivity and 100% specificity.

Ultrasensitive ctDNA Test Shows Promise for Lung Cancer Monitoring

Dec 11, 2025 | Lung Cancer

A study of 431 patients demonstrates the test can detect cancer recurrence months ahead of standard imaging.

Blood Test May Match CT for Early Lung Cancer Detection

Nov 25, 2025 | Lung Cancer

The Mercy Halo test demonstrates performance similar to low-dose CT screening with the potential to reach underscreened populations.

Breath Test Technology Shows Promise for Early Lung Cancer Detection

Nov 7, 2025 | Lung Cancer

University of Texas at Dallas researchers combine electrochemical biosensors with AI to identify volatile organic compounds linked to thoracic cancers.

OncoHost Receives New York State Laboratory Permit for Precision Oncology Test

Oct 23, 2025 | Lung Cancer

The permit enables the company to offer its PROphetNSCLC test to physicians and patients across New York State, completing nationwide availability.

AI-Powered Blood Test Shows Promise for Early Lung Cancer Detection

Oct 1, 2025 | Lung Cancer

A new blood-based test that combines four protein markers with artificial intelligence has demonstrated potential for early lung cancer detection in a multicenter retrospective study.

Why Closing Lung Cancer’s Diagnostic Gap Will Require New Lab Strategies

Sep 25, 2025 | Lung Cancer

On World Lung Day, Reveal Dx board member Mat Brevard discusses why current diagnostic tools fall short—and how new approaches could improve accuracy and outcomes.

Large Clinical Trial to Assess Nasal Swab Test for Guiding Lung Cancer Care

Sep 24, 2025 | Lung Cancer

The 2,400-patient study evaluates the Percepta Nasal Swab test’s ability to guide management decisions for patients with lung nodules.

Clinical Study to Evaluate ctDNA Test for Guiding Lung Cancer Treatment

Sep 22, 2025 | Lung Cancer

Haystack Oncology and Rutgers Cancer Institute collaborate on phase II trial examining minimal residual disease testing in stage II/III NSCLC patients.